Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Built for clinicians who prioritize efficiency and consistency, the 40 mL configuration increases available volume while preserving the same streamlined, single-spin workflow
FDA has separately warned about injectable NAD+ and glutathione quality FDA has received adverse-event reports after NAD+ injectable drugs, including severe chills, shaking, vomiting, and fatigue consistent with excessive endotoxin exposure
Month four was when things clicked into place
Outside the US it is supplied as a research-grade peptide and is not approved for human use by any major regulator
PMCID: PMC6812410
US$ 22.10
US$ 23.57
US$ 28.43
US$ 29.57
US$ 20.65
US$ 23.19
US$ 28.69
